Endoscopic day case antireflux radiofrequency (Stretta) therapy improves quality of life and reduce proton pump inhibitor (PPI) dependency in patients with gastro-oesophageal reflux disease: a prospective study from a UK tertiary centre.
Yirupaiahgari K S ViswanathNicola MaguireReece-Bolton ObuobiAnjan DharSiby PunnoosePublished in: Frontline gastroenterology (2018)
There are currently few effective therapeutic alternatives to antireflux surgery for refractory GORD. This series corroborates the value and safety of Stretta as a viable option for selected patients who are unwilling or unable to undergo an operation. Stretta improves quality of life and decreases PPI dependency in selected patients with GORD.
Keyphrases
- end stage renal disease
- newly diagnosed
- ejection fraction
- ultrasound guided
- minimally invasive
- chronic kidney disease
- prognostic factors
- protein protein
- stem cells
- coronary artery disease
- small molecule
- cell therapy
- bone marrow
- atrial fibrillation
- surgical site infection
- percutaneous coronary intervention
- electron transfer